These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 24957719)
1. Nucleic acid testing of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus 1, 2 in blood donors in the General University Hospital, Prague. Dušková D; Darebníček L Acta Virol; 2014; 58(2):146-51. PubMed ID: 24957719 [TBL] [Abstract][Full Text] [Related]
2. Routine screening of blood donations at Qingdao central blood bank, China, for hepatitis B virus (HBV) DNA with a real-time, multiplex nucleic acid test for HBV, hepatitis C virus, and human immunodeficiency virus Types 1 and 2. Yang Z; Xu L; Liu L; Feng Q; Zhang L; Ma W; Saldanha J; Wang M; Zhao L Transfusion; 2013 Oct; 53(10 Pt 2):2538-44. PubMed ID: 23480568 [TBL] [Abstract][Full Text] [Related]
3. Deceased organ donor screening for human immunodeficiency virus, hepatitis B virus and hepatitis C virus: Discordant serology and nucleic acid testing results. Theodoropoulos N; Nowicki MJ; Chinchilla-Reyes C; Dionne S; Jaramillo A; Mone T; Hasz R; Jendrisak MD; Ladner DP; Ison MG Transpl Infect Dis; 2018 Feb; 20(1):. PubMed ID: 29178242 [TBL] [Abstract][Full Text] [Related]
4. Analytical and clinical performance evaluation of the cobas TaqScreen MPX Test for use on the cobas s 201 system. Ohhashi Y; Pai A; Halait H; Ziermann R J Virol Methods; 2010 May; 165(2):246-53. PubMed ID: 20152864 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of the Roche cobas s 201 system and cobas TaqScreen multiplex test for blood screening: a European multicenter study. Jarvis L; Becker J; Tender A; Cleland A; Queiros L; Aquiar A; Azevedo J; Aprili G; Bressan F; Torres P; Nieto S; Ursitti A; Montoro J; Vila E; Ramada C; Saldanha J Transfusion; 2008 Sep; 48(9):1853-61. PubMed ID: 18513254 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of a multiplex human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus nucleic acid testing assay to detect viremic blood donors in northern Thailand. Nantachit N; Thaikruea L; Thongsawat S; Leetrakool N; Fongsatikul L; Sompan P; Fong YL; Nichols D; Ziermann R; Ness P; Nelson KE Transfusion; 2007 Oct; 47(10):1803-8. PubMed ID: 17880604 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of two, commercial, multi-dye, nucleic acid amplification technology tests, for HBV/HCV/HIV-1/HIV-2 and B19V/HAV, for screening blood and plasma for further manufacture. Müller MM; Fraile MI; Hourfar MK; Peris LB; Sireis W; Rubin MG; López EM; Rodriguez GT; Seifried E; Saldanha J; Schmidt M Vox Sang; 2013 Jan; 104(1):19-29. PubMed ID: 23252689 [TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of triplex nucleic acid test assays in United States blood donors. Stramer SL; Krysztof DE; Brodsky JP; Fickett TA; Reynolds B; Dodd RY; Kleinman SH Transfusion; 2013 Oct; 53(10 Pt 2):2525-37. PubMed ID: 23550838 [TBL] [Abstract][Full Text] [Related]
9. Human immunodeficiency virus-1 and hepatitis C virus RNA among South African blood donors: estimation of residual transfusion risk and yield of nucleic acid testing. Fang CT; Field SP; Busch MP; Heyns Adu P Vox Sang; 2003 Jul; 85(1):9-19. PubMed ID: 12823725 [TBL] [Abstract][Full Text] [Related]
10. Nationwide nucleic acid amplification testing of hepatitis B virus, hepatitis C virus and human immunodeficiency virus type 1 for blood transfusion and follow-up study of nucleic acid amplification positive donors. Japanese Red Cross NAT Screening Research Group Jpn J Infect Dis; 2000 Jun; 53(3):116-23. PubMed ID: 10957709 [TBL] [Abstract][Full Text] [Related]
11. High throughput screening of 16 million serologically negative blood donors for hepatitis B virus, hepatitis C virus and human immunodeficiency virus type-1 by nucleic acid amplification testing with specific and sensitive multiplex reagent in Japan. Mine H; Emura H; Miyamoto M; Tomono T; Minegishi K; Murokawa H; Yamanaka R; Yoshikawa A; Nishioka K; J Virol Methods; 2003 Sep; 112(1-2):145-51. PubMed ID: 12951223 [TBL] [Abstract][Full Text] [Related]
12. Automated multiplex assay system for simultaneous detection of hepatitis B virus DNA, hepatitis C virus RNA, and human immunodeficiency virus type 1 RNA. Meng Q; Wong C; Rangachari A; Tamatsukuri S; Sasaki M; Fiss E; Cheng L; Ramankutty T; Clarke D; Yawata H; Sakakura Y; Hirose T; Impraim C J Clin Microbiol; 2001 Aug; 39(8):2937-45. PubMed ID: 11474017 [TBL] [Abstract][Full Text] [Related]
13. The first large-scale nucleic acid amplification testing (NAT) of donated blood using multiplex reagent for simultaneous detection of HBV, HCV, and HIV-1 and significance of NAT for HBV. Ohnuma H; Tanaka T; Yoshikawa A; Murokawa H; Minegishi K; Yamanaka R; Lizuka HY; Miyamoto M; Satoh S; Nakahira S; Tomono T; Murozuka T; Takeda Y; Doi Y; Mine H; Yokoyama S; Hirose T; Nishioka K; Microbiol Immunol; 2001; 45(9):667-72. PubMed ID: 11694079 [TBL] [Abstract][Full Text] [Related]
14. Comparative evaluation of a triplex nucleic acid test for detection of HBV DNA, HCV RNA, and HIV-1 RNA, with the Procleix Tigris System. Xiao X; Zhai J; Zeng J; Tian C; Wu H; Yu Y J Virol Methods; 2013 Feb; 187(2):357-61. PubMed ID: 23142222 [TBL] [Abstract][Full Text] [Related]
15. Head-to-head comparison of Enzyme Linked Immunosorbent Assay (ELISA) and Enhanced Chemiluminescence Immunoassay (ECLIA) for the detection of Transfusion Transmitted Disease (TTD) Markers; HIV, HCV and HBV in blood donors, in India. Tiwari AK; Upadhyay AP; Arora D; Wadhwa T; Aggarwal G; Pabbi S; Luthra AS; Rawat SS J Virol Methods; 2020 Nov; 285():113962. PubMed ID: 32860798 [TBL] [Abstract][Full Text] [Related]
16. Detection of infections with hepatitis B virus, hepatitis C virus, and human immunodeficiency virus by analyses of dried blood spots--performance characteristics of the ARCHITECT system and two commercial assays for nucleic acid amplification. Ross RS; Stambouli O; Grüner N; Marcus U; Cai W; Zhang W; Zimmermann R; Roggendorf M Virol J; 2013 Mar; 10():72. PubMed ID: 23497102 [TBL] [Abstract][Full Text] [Related]
17. The characteristics of hepatitis B surface antigen (HBsAg)-negative hepatitis B virus (HBV) infection in Chinese blood donors: a follow-up study of donors tested negative for HBsAg and reactive for simultaneous nucleic acid testing of HBV, hepatitis C virus, and human immunodeficiency virus. Guo Z; Fu P; Yin Y; Wang F; Yin Y; Wang J; Liu Y Transfusion; 2017 Mar; 57(3pt2):832-840. PubMed ID: 28164313 [TBL] [Abstract][Full Text] [Related]
18. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus. Li L; Chen PJ; Chen MH; Chak KF; Lin KS; Tsai SJ Transfusion; 2008 Jun; 48(6):1198-206. PubMed ID: 18422856 [TBL] [Abstract][Full Text] [Related]
19. Comparison of two automated nucleic acid testing systems for simultaneous detection of human immunodeficiency virus and hepatitis C virus RNA and hepatitis B virus DNA. Margaritis AR; Brown SM; Seed CR; Kiely P; D'Agostino B; Keller AJ Transfusion; 2007 Oct; 47(10):1783-93. PubMed ID: 17880602 [TBL] [Abstract][Full Text] [Related]
20. [Safe blood in the absence of viral infections due to HBV, HCV and HIV in serological window period in donors]. Contreras AM; Reta CB; Torres O; Celis A; Domínguez J Salud Publica Mex; 2011; 53 Suppl 1():S13-8. PubMed ID: 21877067 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]